These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 24206228)

  • 1. Recent advances in mass spectrometry: data independent analysis and hyper reaction monitoring.
    Law KP; Lim YP
    Expert Rev Proteomics; 2013 Dec; 10(6):551-66. PubMed ID: 24206228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection and quantification of proteins in clinical samples using high resolution mass spectrometry.
    Gallien S; Domon B
    Methods; 2015 Jun; 81():15-23. PubMed ID: 25843604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review on mass spectrometry-based quantitative proteomics: Targeted and data independent acquisition.
    Vidova V; Spacil Z
    Anal Chim Acta; 2017 Apr; 964():7-23. PubMed ID: 28351641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving SRM assay development: a global comparison between triple quadrupole, ion trap, and higher energy CID peptide fragmentation spectra.
    de Graaf EL; Altelaar AF; van Breukelen B; Mohammed S; Heck AJ
    J Proteome Res; 2011 Sep; 10(9):4334-41. PubMed ID: 21726076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative measurements of N-linked glycoproteins in human plasma by SWATH-MS.
    Liu Y; Hüttenhain R; Surinova S; Gillet LC; Mouritsen J; Brunner R; Navarro P; Aebersold R
    Proteomics; 2013 Apr; 13(8):1247-56. PubMed ID: 23322582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantification of proteins in urine samples using targeted mass spectrometry methods.
    Khristenko N; Domon B
    Methods Mol Biol; 2015; 1243():207-20. PubMed ID: 25384748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in high-resolution quantitative proteomics: implications for clinical applications.
    Gallien S; Domon B
    Expert Rev Proteomics; 2015; 12(5):489-98. PubMed ID: 26189960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in targeted proteomics for clinical applications.
    Domon B; Gallien S
    Proteomics Clin Appl; 2015 Apr; 9(3-4):423-31. PubMed ID: 25504492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selected reaction monitoring applied to proteomics.
    Gallien S; Duriez E; Domon B
    J Mass Spectrom; 2011 Mar; 46(3):298-312. PubMed ID: 21394846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parallel Reaction Monitoring: A Targeted Experiment Performed Using High Resolution and High Mass Accuracy Mass Spectrometry.
    Rauniyar N
    Int J Mol Sci; 2015 Dec; 16(12):28566-81. PubMed ID: 26633379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using data-independent, high-resolution mass spectrometry in protein biomarker research: perspectives and clinical applications.
    Sajic T; Liu Y; Aebersold R
    Proteomics Clin Appl; 2015 Apr; 9(3-4):307-21. PubMed ID: 25504613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Considerations on selected reaction monitoring experiments: implications for the selectivity and accuracy of measurements.
    Domon B
    Proteomics Clin Appl; 2012 Dec; 6(11-12):609-14. PubMed ID: 23112131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Technical considerations for large-scale parallel reaction monitoring analysis.
    Gallien S; Bourmaud A; Kim SY; Domon B
    J Proteomics; 2014 Apr; 100():147-59. PubMed ID: 24200835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mass spectrometric discovery and selective reaction monitoring (SRM) of putative protein biomarker candidates in first trimester Trisomy 21 maternal serum.
    Lopez MF; Kuppusamy R; Sarracino DA; Prakash A; Athanas M; Krastins B; Rezai T; Sutton JN; Peterman S; Nicolaides K
    J Proteome Res; 2011 Jan; 10(1):133-42. PubMed ID: 20499897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In-depth proteomics of ovarian cancer ascites: combining shotgun proteomics and selected reaction monitoring mass spectrometry.
    Elschenbroich S; Ignatchenko V; Clarke B; Kalloger SE; Boutros PC; Gramolini AO; Shaw P; Jurisica I; Kislinger T
    J Proteome Res; 2011 May; 10(5):2286-99. PubMed ID: 21491939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in targeted proteomics and applications to biomedical research.
    Shi T; Song E; Nie S; Rodland KD; Liu T; Qian WJ; Smith RD
    Proteomics; 2016 Aug; 16(15-16):2160-82. PubMed ID: 27302376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How specific is my SRM?: The issue of precursor and product ion redundancy.
    Sherman J; McKay MJ; Ashman K; Molloy MP
    Proteomics; 2009 Mar; 9(5):1120-3. PubMed ID: 19253278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Automated SWATH Data Analysis Using Targeted Extraction of Ion Chromatograms.
    Röst HL; Aebersold R; Schubert OT
    Methods Mol Biol; 2017; 1550():289-307. PubMed ID: 28188537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extended Range Proteomic Analysis (ERPA): a new and sensitive LC-MS platform for high sequence coverage of complex proteins with extensive post-translational modifications-comprehensive analysis of beta-casein and epidermal growth factor receptor (EGFR).
    Wu SL; Kim J; Hancock WS; Karger B
    J Proteome Res; 2005; 4(4):1155-70. PubMed ID: 16083266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selected reaction monitoring mass spectrometry: a methodology overview.
    Ebhardt HA
    Methods Mol Biol; 2014; 1072():209-22. PubMed ID: 24136525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.